[Behavior and pathophysiological significance of adrenomedullin in essential hypertension]. 2000

T Nishikimi, and K Kangawa
Division of Hypertension and Cardiorenal Disease, Dokkyo University Medical School of Medicine.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D053607 Adrenomedullin A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion. ADM (1-52),ADM(1-52),Adrenomedullin (1-52),PAMP(1-20)NH2,Proadrenomedullin (1-20),Proadrenomedullin N-Terminal 20 Peptide,Proadrenomedullin N Terminal 20 Peptide

Related Publications

T Nishikimi, and K Kangawa
January 1989, Clinical and experimental hypertension. Part A, Theory and practice,
T Nishikimi, and K Kangawa
September 2004, Nihon rinsho. Japanese journal of clinical medicine,
T Nishikimi, and K Kangawa
June 2013, Sheng li ke xue jin zhan [Progress in physiology],
T Nishikimi, and K Kangawa
January 1996, Hypertension (Dallas, Tex. : 1979),
T Nishikimi, and K Kangawa
January 1980, Pharmacology & therapeutics,
T Nishikimi, and K Kangawa
June 1977, Archives of internal medicine,
T Nishikimi, and K Kangawa
September 2004, Nihon rinsho. Japanese journal of clinical medicine,
T Nishikimi, and K Kangawa
February 1999, Journal of hypertension,
T Nishikimi, and K Kangawa
June 2006, Cardiovascular & hematological disorders drug targets,
T Nishikimi, and K Kangawa
January 1982, Terapevticheskii arkhiv,
Copied contents to your clipboard!